RespireRx Pharmaceuticals Inc (RSPI)

[LTListener]

I would tend to agree. Considering that NIH desires more expiditious results and assuming animal trials to test addicitive liability are well underway or in progress, I would think there should be some early indication as to whether there is anything to stall going directly into phase 1 human trials. BP would almost be necessary at this point or highly encouraged to pursue.